Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Research Biosimilar

Research Grade Onercept

Catalog #:   DHB94438 Specific References (50) DATASHEET
Isotype: Glycoprotein TNF-bp (Tumor necrosis factor-binding protein, TBP1)
Applications: Research Grade Biosimilar
Expression system: Mammalian Cells
Accession: P01375
Overview

Catalog No.

DHB94438

Expression system

Mammalian Cells

Species reactivity

Human

Isotype

Glycoprotein TNF-bp (Tumor necrosis factor-binding protein, TBP1)

Clonality

Monoclonal

Applications

Research Grade Biosimilar

Target

TNF, Tumor necrosis factor ligand superfamily member 2, N-terminal fragment, ICD2, NTF, TNF-a, TNF-alpha, Tumor necrosis factor, TNFSF2, TNFA, Cachectin, ICD1

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P01375

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Alternative Names

Onercept (USAN/INN), r-hTBP, R-HTBP-1, R-TBP-1, rTBP-1, TBP, TBP 1, TBP I, TNF-BP1, Tumour necrosis factor binding protein 1

Clone ID

Onercept

Note

For research use only. Not suitable for clinical or therapeutic use.

Data Image
References

Effect of traumatic brain injury on cognitive function in mice lacking p55 and p75 tumor necrosis factor receptors., PMID:19388357

Recombinant human TNF-binding protein-1 (rhTBP-1) treatment delays both symptoms progression and motor neuron loss in the wobbler mouse., PMID:18201889

Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis., PMID:18219394

Tumor necrosis factor alpha mediates the lethal hepatotoxic effects of poly(I:C) in D-galactosamine-sensitized mice., PMID:18331798

Tumor necrosis factor alpha is a proximal mediator of synergistic hepatotoxicity from trovafloxacin/lipopolysaccharide coexposure., PMID:18820134

Local ocular immunomodulation resulting from electrotransfer of plasmid encoding soluble TNF receptors in the ciliary muscle., PMID:19321795

Biological therapy of inflammatory bowel disease., PMID:19341184

Efficacy, pharmacodynamics, and safety of VX-702, a novel p38 MAPK inhibitor, in rheumatoid arthritis: results of two randomized, double-blind, placebo-controlled clinical studies., PMID:19404957

Advances of molecular clinical pharmacology in gastroenterology and hepatology., PMID:19433977

Effects of ciliary muscle plasmid electrotransfer of TNF-alpha soluble receptor variants in experimental uveitis., PMID:19440225

Toxoplasma gondii: the role of IFN-gamma, TNFRp55 and iNOS in inflammatory changes during infection., PMID:19501090

[Perspectives in inflammatory bowel diseases treatment]., PMID:19606725

TNFR1-dependent regulation of myeloid cell function in experimental autoimmune uveoretinitis., PMID:19635911

Lack of effect of TNFalpha blockade therapy on circulating adiponectin levels in patients with autoimmune disease: results from two independent prospective studies., PMID:19640853

Biologic targeting in the treatment of inflammatory bowel diseases., PMID:19707398

TNF receptor p55 and IL-8(72) and IL-8(77) isoforms: blood and urine levels in breast cancer patients., PMID:19908942

Endometriosis: in search of optimal treatment., PMID:20186112

Interaction of adenosine 3',5'-cyclic monophosphate and tumor necrosis factor-alpha on serum amyloid A3 expression in mouse granulosa cells: dependence on CCAAT-enhancing binding protein-beta isoform., PMID:20444945

Gastric and intestinal barrier impairment in tropical enteropathy and HIV: limited impact of micronutrient supplementation during a randomised controlled trial., PMID:20604937

Clinical development of onercept, a tumor necrosis factor binding protein, in psoriasis., PMID:20718590

Circulating TNF alpha receptor levels identify older adults who fail to regain weight after acute weight loss., PMID:20922351

Kinin B1 receptors mediate depression-like behavior response in stressed mice treated with systemic E. coli lipopolysaccharide., PMID:21194425

Characterization of TNF receptor subtype expression and signaling on pulmonary endothelial cells in mice., PMID:21378027

Chronic OVA allergen challenged TNF p55/p75 receptor deficient mice have reduced airway remodeling., PMID:21382533

TNFRp55 modulates IL-6 and nitric oxide responses following Yersinia lipopolysaccharide stimulation in peritoneal macrophages., PMID:21802165

Selective inhibition of intra-alveolar p55 TNF receptor attenuates ventilator-induced lung injury., PMID:22156959

Brucella abortus-infected macrophages modulate T lymphocytes to promote osteoclastogenesis via IL-17., PMID:22901753

TNFRp55 controls regulatory T cell responses in Yersinia-induced reactive arthritis., PMID:23207279

Tumor necrosis factor in traumatic brain injury: effects of genetic deletion of p55 or p75 receptor., PMID:23611870

Modulation of gut barrier function in patients with obstructive jaundice using probiotic LP299v., PMID:23820246

Amelioration of liver injury by continuously targeted intervention against TNFRp55 in rats with acute-on-chronic liver failure., PMID:23874752

HSV-mediated p55TNFSR reduces neuropathic pain induced by HIV gp120 in rats through CXCR4 activity., PMID:24451118

New biologic therapeutics for ulcerative colitis and Crohn's disease., PMID:24502344

Soluble TNFRp75 regulates host protective immunity against Mycobacterium tuberculosis., PMID:24569452

Bone mineral density and bone turnover in non-cirrhotic patients with chronic hepatitis C and sustained virological response to antiviral therapy with peginterferon-alfa and ribavirin., PMID:24676843

Impact of tumor necrosis factor receptor p55 deficiency in susceptibility of C57BL/6 mice to infection with Leishmania (Leishmania) amazonensis., PMID:24856420

Decrease in neuroimmune activation by HSV-mediated gene transfer of TNFα soluble receptor alleviates pain in rats with diabetic neuropathy., PMID:24880032

The interaction between menstrual cycle, Tumour Necrosis Factor alpha receptors and sex hormones in healthy non-obese women--results from an observational study., PMID:25292131

Cooperative role of lymphotoxin β receptor and tumor necrosis factor receptor p55 in murine liver regeneration., PMID:26708145

Mechanism of Action of Anti-TNF Therapy in Inflammatory Bowel Disease., PMID:26896086

TNFRp55 deficiency promotes the development of ectopic endometriotic-like lesions in mice., PMID:28676525

The p55TNFR-IKK2-Ripk3 axis orchestrates arthritis by regulating death and inflammatory pathways in synovial fibroblasts., PMID:29434332

IL-12/23p40 overproduction by dendritic cells leads to an increased Th1 and Th17 polarization in a model of Yersinia enterocolitica-induced reactive arthritis in TNFRp55-/- mice., PMID:29494692

Circadian rhythms of factors involved in luteal regression are modified in p55 tumour necrosis factor receptor (TNFRp55)-deficient mice., PMID:29903342

Non-viral ocular gene therapy, pEYS606, for the treatment of non-infectious uveitis: Preclinical evaluation of the medicinal product., PMID:30009894

Peripheral Neuroimmunoendocrine Interactions: Contribution of TNFRp55 to the Circadian Synchronization of Progesterone and Cytokine Production in Joints of Mice in Late Pregnancy., PMID:30304732

Endometriosis progression in tumor necrosis factor receptor p55-deficient mice: Impact on oxidative/nitrosative stress and metallomic profile., PMID:30732877

Reduced inflammatory state promotes reinnervation of endometriotic-like lesions in TNFRp55 deficient mice., PMID:31070761

Dendritic Cells of Mesenteric and Regional Lymph Nodes Contribute to Yersinia enterocolitica O:3-Induced Reactive Arthritis in TNFRp55-/- Mice., PMID:32122996

TNFRp75-dependent immune regulation of alveolar macrophages and neutrophils during early Mycobacterium tuberculosis and Mycobacterium bovis BCG infection., PMID:33020922

Datasheet

Document Download

Research Grade Onercept.pdf

 

$ 420
Product specifications
100 μg 420 1 mg 1680 5 mg 5040

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Research Grade Onercept [DHB94438]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only